Trademark Overview
On Wednesday, October 16, 2024, a trademark application was filed for TRILLIUM with the United States Patent and Trademark Office. The USPTO has given the TRILLIUM trademark a serial number of 98804622. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, October 16, 2024. This trademark is owned by Ratio Therapeutics, Inc.. The TRILLIUM trademark is filed in the Pharmaceutical Products category with the following description:
Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use